SI9520081B - Uporaba tiazolnih in tiadiazolnih spojin - Google Patents
Uporaba tiazolnih in tiadiazolnih spojin Download PDFInfo
- Publication number
- SI9520081B SI9520081B SI9520081A SI9520081A SI9520081B SI 9520081 B SI9520081 B SI 9520081B SI 9520081 A SI9520081 A SI 9520081A SI 9520081 A SI9520081 A SI 9520081A SI 9520081 B SI9520081 B SI 9520081B
- Authority
- SI
- Slovenia
- Prior art keywords
- alkyl
- formula
- stands
- thiadiazole compounds
- halogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Lubricants (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4425145A DE4425145A1 (de) | 1994-07-15 | 1994-07-15 | Verwendung von Thiazol- und Thiadiazolverbindungen |
| PCT/EP1995/002783 WO1996002249A1 (de) | 1994-07-15 | 1995-07-14 | Verwendung von thiazol- und thiadiazolverbindungen als d3 dopaminrezeptorligand |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SI9520081A SI9520081A (en) | 1997-08-31 |
| SI9520081B true SI9520081B (sl) | 2003-12-31 |
Family
ID=6523324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9520081A SI9520081B (sl) | 1994-07-15 | 1995-07-14 | Uporaba tiazolnih in tiadiazolnih spojin |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5958923A (cs) |
| EP (1) | EP0768879B1 (cs) |
| JP (1) | JPH10502915A (cs) |
| KR (1) | KR100443216B1 (cs) |
| CN (1) | CN1152872A (cs) |
| AT (1) | ATE234616T1 (cs) |
| AU (1) | AU712422B2 (cs) |
| BR (1) | BR9508295A (cs) |
| CA (1) | CA2195240A1 (cs) |
| CZ (1) | CZ292909B6 (cs) |
| DE (2) | DE4425145A1 (cs) |
| ES (1) | ES2194918T3 (cs) |
| FI (1) | FI970149A0 (cs) |
| HU (1) | HUT77554A (cs) |
| IL (1) | IL114600A (cs) |
| MX (1) | MX9700429A (cs) |
| NO (1) | NO312154B1 (cs) |
| SI (1) | SI9520081B (cs) |
| TW (1) | TW414793B (cs) |
| WO (1) | WO1996002249A1 (cs) |
| ZA (1) | ZA955869B (cs) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19600934A1 (de) | 1996-01-12 | 1997-07-17 | Basf Ag | Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung |
| DE19728996A1 (de) * | 1997-07-07 | 1999-01-14 | Basf Ag | Triazolverbindungen und deren Verwendung |
| SK4782001A3 (en) | 1998-10-08 | 2001-11-06 | Smithkline Beecham Plc | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| ES2311012T3 (es) * | 2000-03-27 | 2009-02-01 | ABBOTT GMBH & CO. KG | Ligandos del receptor d3 de la dopamina para el tratamiento de la adiccion. |
| HUP0103987A3 (en) * | 2001-09-28 | 2004-11-29 | Richter Gedeon Vegyeszet | Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates |
| AU2003205747A1 (en) * | 2002-03-06 | 2003-09-16 | Merck Patent Gmbh | Thiazole derivatives and their use d2- and 5-ht1a-receptor ligands |
| CA2498936C (en) | 2002-09-14 | 2013-02-12 | Gov't Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services | Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| US20040204422A1 (en) | 2003-04-14 | 2004-10-14 | Abbott Gmbh & Co. Kg. | N-[(Piperazinyl)hetaryl]arylsulfonamide compounds |
| US7320979B2 (en) * | 2003-04-14 | 2008-01-22 | Abbott Gmbh & Co. Kg. | N-[(piperazinyl)hetaryl]arylsulfonamide compounds |
| DE10358004A1 (de) | 2003-12-11 | 2005-07-14 | Abbott Gmbh & Co. Kg | Ketolactam-Verbindungen und ihre Verwendung |
| US20050137186A1 (en) | 2003-12-18 | 2005-06-23 | Abbott Gmbh & Co. Kg. | Tetrahydrobenzazepines and their use |
| ATE529114T1 (de) | 2003-12-18 | 2011-11-15 | Abbott Gmbh & Co Kg | Tetrahydrobenzazepine und ihre verwendung in der modulation des dopamin-d3-rezeptors |
| DE102004027359A1 (de) * | 2004-06-04 | 2005-12-29 | Abbott Gmbh & Co. Kg | Pyridin-2-onverbindungen und deren Verwendung |
| DE102004027358A1 (de) | 2004-06-04 | 2005-12-29 | Abbott Gmbh & Co. Kg | Pyrimidinverbindungen und ihre Verwendung |
| ES2340941T3 (es) * | 2004-08-09 | 2010-06-11 | ABBOTT GMBH & CO. KG | Compuestos de 4-piperazinil-pirimidina adecuados para tretar trastornos que responden a modulacion del receptor d 3 de dopamina. |
| GB0512099D0 (en) * | 2005-06-14 | 2005-07-20 | Glaxo Group Ltd | Compounds |
| JO2769B1 (en) | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor |
| JO2849B1 (en) | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
| HRP20120913T1 (hr) * | 2007-04-23 | 2012-12-31 | Janssen Pharmaceutica N.V. | Derivati 4-alkoksipiridazina kao brzo disocirajuä†i antagonisti dopamin 2 receptora |
| EP2148879B1 (en) * | 2007-04-23 | 2012-11-28 | Janssen Pharmaceutica, N.V. | Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
| ES2622161T3 (es) * | 2008-07-31 | 2017-07-05 | Janssen Pharmaceutica, N.V. | Piridinas sustituidas con piperazin-1-il-trifluorometilo como antagonistas del receptor de la dopamina 2 de disociación rápida |
| US10870660B2 (en) | 2016-07-28 | 2020-12-22 | Shionogi & Co., Ltd. | Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect |
| WO2019146740A1 (ja) | 2018-01-26 | 2019-08-01 | 塩野義製薬株式会社 | ドーパミンｄ３受容体拮抗作用を有する環式化合物 |
| CN111801330B (zh) | 2018-01-26 | 2024-04-05 | 盐野义制药株式会社 | 具有多巴胺d3受体拮抗作用的稠环化合物 |
| IL314361B2 (en) | 2022-01-29 | 2025-04-01 | Suven Life Sciences Ltd | Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disorders |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1053085A (cs) * | 1964-03-26 | |||
| DE1695410A1 (de) * | 1967-04-20 | 1971-04-08 | Merck Patent Gmbh | Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen |
| US3522846A (en) * | 1968-10-04 | 1970-08-04 | Robert V New | Method and apparatus for production amplification by spontaneous emission of radiation |
| US3717651A (en) * | 1970-04-20 | 1973-02-20 | Shell Oil Co | Thiazoles |
| US4074049A (en) * | 1976-11-19 | 1978-02-14 | The Dow Chemical Company | Antithrombotic 1,3,4-thiadiazole |
| US4943580A (en) * | 1987-03-09 | 1990-07-24 | Janssen Pharmaceutica N.V. | Anti-histaminic benzimidazole, imidazopyridine and purine derivatives |
| NZ223654A (en) * | 1987-03-09 | 1990-03-27 | Janssen Pharmaceutica Nv | 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions |
| US4935424A (en) * | 1988-05-27 | 1990-06-19 | Warner-Lambert Company | 4 or 5-(substituted piperazinylalkyl)-2-aminothiazoles as antipsychotic agents |
| FR2636628B1 (fr) * | 1988-08-25 | 1990-12-28 | Sanofi Sa | Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant |
| DE3923675A1 (de) * | 1989-07-18 | 1991-01-24 | Basf Ag | Amonoalkylsubstituierte 2-aminothiazole und diese enthaltende therapeutische mittel |
| US5273977A (en) * | 1990-11-05 | 1993-12-28 | Warner-Lambert Company | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| DE4119755A1 (de) * | 1991-06-15 | 1992-12-17 | Basf Ag | Aminoalkylsubstituierte 2-amino-1,3,4-thiadiazole, ihre herstellung und verwendung |
| DE4119757A1 (de) * | 1991-06-15 | 1992-12-17 | Basf Ag | Aminoalkylsubstituierte thiazolin-2-one, ihre herstellung und verwendung |
| DE4119758A1 (de) * | 1991-06-15 | 1992-12-17 | Basf Ag | Aminoalkylsubstituierte 2-amino-5-mercaptothiadiazole, ihre herstellung und verwendung |
| DE4119756A1 (de) * | 1991-06-15 | 1992-12-17 | Basf Ag | Aminoalkylsubstituierte 5-mercaptothiazole, ihre herstellung und verwendung |
| ZA9610046B (en) * | 1995-12-01 | 1997-07-10 | Ciba Geigy | Process for preparing 2-chlorothiazole compounds |
-
1994
- 1994-07-15 DE DE4425145A patent/DE4425145A1/de not_active Withdrawn
-
1995
- 1995-07-14 FI FI970149A patent/FI970149A0/fi not_active IP Right Cessation
- 1995-07-14 ZA ZA955869A patent/ZA955869B/xx unknown
- 1995-07-14 MX MX9700429A patent/MX9700429A/es not_active IP Right Cessation
- 1995-07-14 WO PCT/EP1995/002783 patent/WO1996002249A1/de not_active Ceased
- 1995-07-14 US US08/765,915 patent/US5958923A/en not_active Expired - Lifetime
- 1995-07-14 SI SI9520081A patent/SI9520081B/sl not_active IP Right Cessation
- 1995-07-14 BR BR9508295A patent/BR9508295A/pt not_active Application Discontinuation
- 1995-07-14 KR KR1019970700268A patent/KR100443216B1/ko not_active Expired - Fee Related
- 1995-07-14 CA CA002195240A patent/CA2195240A1/en not_active Abandoned
- 1995-07-14 ES ES95926897T patent/ES2194918T3/es not_active Expired - Lifetime
- 1995-07-14 JP JP8504702A patent/JPH10502915A/ja not_active Ceased
- 1995-07-14 AU AU31115/95A patent/AU712422B2/en not_active Ceased
- 1995-07-14 CZ CZ199794A patent/CZ292909B6/cs not_active IP Right Cessation
- 1995-07-14 HU HU9700115A patent/HUT77554A/hu unknown
- 1995-07-14 AT AT95926897T patent/ATE234616T1/de not_active IP Right Cessation
- 1995-07-14 IL IL11460095A patent/IL114600A/xx not_active IP Right Cessation
- 1995-07-14 CN CN95194140A patent/CN1152872A/zh active Pending
- 1995-07-14 DE DE59510596T patent/DE59510596D1/de not_active Expired - Lifetime
- 1995-07-14 EP EP95926897A patent/EP0768879B1/de not_active Expired - Lifetime
- 1995-08-08 TW TW084108222A patent/TW414793B/zh not_active IP Right Cessation
-
1997
- 1997-01-14 NO NO19970164A patent/NO312154B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW414793B (en) | 2000-12-11 |
| WO1996002249A1 (de) | 1996-02-01 |
| ES2194918T3 (es) | 2003-12-01 |
| MX9700429A (es) | 1998-05-31 |
| CN1152872A (zh) | 1997-06-25 |
| HUT77554A (hu) | 1998-05-28 |
| US5958923A (en) | 1999-09-28 |
| DE59510596D1 (de) | 2003-04-24 |
| KR970704438A (ko) | 1997-09-06 |
| FI970149A7 (fi) | 1997-01-14 |
| CA2195240A1 (en) | 1996-02-01 |
| HU9700115D0 (en) | 1997-02-28 |
| IL114600A (en) | 1999-11-30 |
| FI970149L (fi) | 1997-01-14 |
| EP0768879B1 (de) | 2003-03-19 |
| ZA955869B (en) | 1997-01-14 |
| NO970164L (no) | 1997-03-14 |
| KR100443216B1 (ko) | 2004-11-20 |
| DE4425145A1 (de) | 1996-01-18 |
| CZ9497A3 (en) | 1997-09-17 |
| CZ292909B6 (cs) | 2004-01-14 |
| ATE234616T1 (de) | 2003-04-15 |
| AU712422B2 (en) | 1999-11-04 |
| IL114600A0 (en) | 1995-11-27 |
| SI9520081A (en) | 1997-08-31 |
| NO970164D0 (no) | 1997-01-14 |
| FI970149A0 (fi) | 1997-01-14 |
| NO312154B1 (no) | 2002-04-02 |
| BR9508295A (pt) | 1998-01-13 |
| EP0768879A1 (de) | 1997-04-23 |
| AU3111595A (en) | 1996-02-16 |
| JPH10502915A (ja) | 1998-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI9520081B (sl) | Uporaba tiazolnih in tiadiazolnih spojin | |
| SI9520080B (sl) | Substituirane pirimidinske spojine in njihova uporaba | |
| DE69836563T2 (de) | INHIBIERUNG DER p38 KINASE-AKTIVITÄT DURCH DIE VERWENDUNG VON ARYL- UND HETEROARYL-SUBSTITUIERTEN HARNSTOFFEN | |
| SI9520084B (sl) | Uporaba hetrocikličnih spojin kot dopamin-d3-ligandov | |
| RU94019971A (ru) | Производные 1,3-дигидро-2н-имидазо /4,5-в/хинолин-2-она в качестве ингибиторов, фосфодиэстеразы, способ их получения, промежуточные для них, фармацевтическая композиция и способ ее получения | |
| YU85001A (sh) | Derivati 5-fenil-pirimidina | |
| DE60309829D1 (de) | Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon | |
| RU93004675A (ru) | 1,2,4-оксадиазолил-феноксиалкилизоксазолы, их применение в качестве противовирусных агентов, фармацевтическая композиция | |
| HRP20240012T1 (hr) | Derivati 1-((2-(2,2,2-trifluoroetoksi)piridin-4-il)metil)uree kao kcnq potencijatori | |
| RU95114847A (ru) | Гетероциклил-бензоил-гуанидины, способ их получения, фармкомпозиция и способ ее получения | |
| DE69007471T2 (de) | Verfahren zur verhütung oder zur begrenzung einer reperfusionsschädigung. | |
| IT8249354A0 (it) | Derivati di 3-ammino pregn-5-ene eloro sali, procedimento per la loro preparazione, per l'applicazione come medicamenti e composizioni cheli contengono | |
| ES8500247A1 (es) | Un procedimiento para la preparacion de un isomero optico en su forma (-) de un derivado de triazina. | |
| EA200200489A1 (ru) | Новые соединения бензотиадиазина, способ их получения и содержащие их фармацевтические композиции | |
| KR900018112A (ko) | 흥분성 아미노산 길항제 | |
| SI9520094B (sl) | N-substituirani 3-azabiciklo/3.2.0/ heptanski derivati uporabni kot nevroleptiki | |
| IT1256320B (it) | Derivati eterociclici | |
| DK163144C (da) | Diethylaminoalkoxybenzhydrolderivater og farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat og fremgangsmaade til fremstilling heraf | |
| ATE34982T1 (de) | 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxochinol n-3-carbonsaeure-derivate und 7-(pyrrol-1-yl)-1ethyl-1,4-dihydro-4-oxo-1,8-naphtyridin-3carbons|ure-derivate, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel. | |
| DK163182C (da) | Dialkylaminoalkoxybenzylalkoholderivater og farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat og fremgangsmaade til fremstilling deraf | |
| KR890002106A (ko) | 치환된 벤즈 이미다졸, 이의 제조방법, 이를 함유하는 약제학적 제형, 및 이의 용도 | |
| ATE28193T1 (de) | 2-anilino-1,6-dihydro-6-oxo-5pyrimidincarbons|ure-derivate, verfahren zu ihrer herstellung, und diese enthaltende antiallergische wirkstoffe. | |
| CA1320134C (en) | Dissolved composition of [benzo-1,2,4-thiadiazine]-1, 1-dioxide | |
| JPS62138492A (ja) | 新規化合物、その製法及びそれを含む医薬組成物 | |
| KR950701329A (ko) | 벤조티아졸술폰아미드 유도체, 그의 제조법 및 그 용도(Benzothiazolesulfornamide derivative, method for preparing the same, and use thereof) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF | Valid on the event date | ||
| KO00 | Lapse of patent |
Effective date: 20050412 |